Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
26,342,320
-
Share change
-
+26,342,320
-
Total reported value
-
$786,096,000
-
Price per share
-
$29.90
-
Number of holders
-
46
-
Value change
-
+$786,096,000
-
Number of buys
-
46
Institutional Holders of TRICIDA INC - COM (TCDAQ) as of Q2 2018
As of 30 Jun 2018,
TRICIDA INC - COM (TCDAQ) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,342,320 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, BAKER BROS. ADVISORS LP, FMR LLC, venBio Select Advisor LLC, PRICE T ROWE ASSOCIATES INC /MD/, Vivo Capital, LLC, VHCP Management II, LLC, Cormorant Asset Management, LP, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
46
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.